ALLIANCEBERNSTEIN L.P. - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 176 filers reported holding NEVRO CORP in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of NEVRO CORP
ValueSharesWeighting
Q2 2024$445,165
-16.0%
52,870
+44.1%
0.00%
Q1 2024$529,948
-40.2%
36,700
-10.9%
0.00%
Q4 2023$886,624
+12.0%
41,2000.0%0.00%
Q3 2023$791,864
-24.4%
41,2000.0%0.00%
Q2 2023$1,047,304
-29.7%
41,2000.0%0.00%
-100.0%
Q1 2023$1,489,380
-9.2%
41,200
-0.5%
0.00%0.0%
Q4 2022$1,639,876
-22.3%
41,411
-8.6%
0.00%0.0%
Q3 2022$2,111,000
+6.3%
45,3000.0%0.00%0.0%
Q2 2022$1,985,000
-39.8%
45,300
-0.6%
0.00%0.0%
Q1 2022$3,296,000
-10.0%
45,574
+0.8%
0.00%0.0%
Q4 2021$3,664,000
-30.3%
45,2000.0%0.00%
-50.0%
Q3 2021$5,260,000
-54.1%
45,200
-34.6%
0.00%
-60.0%
Q2 2021$11,460,000
+16.5%
69,121
-2.0%
0.01%
+25.0%
Q1 2021$9,838,000
-22.6%
70,521
-3.9%
0.00%
-33.3%
Q4 2020$12,709,000
+24.3%
73,4210.0%0.01%0.0%
Q3 2020$10,228,000
+0.9%
73,421
-13.5%
0.01%0.0%
Q2 2020$10,141,000
+52.6%
84,880
+27.7%
0.01%
+20.0%
Q1 2020$6,646,000
+29.4%
66,470
+52.1%
0.01%
+66.7%
Q4 2019$5,136,000
+42.9%
43,700
+4.5%
0.00%
+50.0%
Q3 2019$3,594,000
+32.6%
41,8000.0%0.00%0.0%
Q2 2019$2,710,000
-59.6%
41,800
-61.0%
0.00%
-50.0%
Q1 2019$6,707,000
+33.4%
107,300
-17.0%
0.00%0.0%
Q4 2018$5,028,000
-55.6%
129,300
-35.0%
0.00%
-42.9%
Q3 2018$11,333,000
-89.2%
198,827
-84.9%
0.01%
-90.4%
Q2 2018$105,130,000
-20.3%
1,316,588
-13.5%
0.07%
-23.2%
Q1 2018$131,916,000
+26.0%
1,522,048
+0.4%
0.10%
+26.7%
Q4 2017$104,685,000
-21.8%
1,516,300
+2.9%
0.08%
-25.0%
Q3 2017$133,910,000
+44.0%
1,473,477
+17.9%
0.10%
+38.9%
Q2 2017$93,002,000
-18.8%
1,249,524
+2.2%
0.07%
-20.9%
Q1 2017$114,537,000
+17.4%
1,222,381
-9.0%
0.09%
+12.3%
Q4 2016$97,595,000
-30.8%
1,343,179
-0.5%
0.08%
-31.9%
Q3 2016$140,960,000
+13.0%
1,350,324
-20.2%
0.12%
+11.2%
Q2 2016$124,770,000
+22.1%
1,691,564
-6.9%
0.11%
+23.0%
Q1 2016$102,203,000
-22.0%
1,816,620
-6.4%
0.09%
-21.6%
Q4 2015$131,011,000
+22.9%
1,940,615
-15.5%
0.11%
+22.0%
Q3 2015$106,580,000
+49.7%
2,297,483
+73.4%
0.09%
+54.2%
Q2 2015$71,201,000
+255.6%
1,324,674
+217.1%
0.06%
+268.8%
Q1 2015$20,025,000
+34.5%
417,806
+8.5%
0.02%
+33.3%
Q4 2014$14,894,000385,1680.01%
Other shareholders
NEVRO CORP shareholders Q3 2018
NameSharesValueWeighting ↓
Engaged Capital LLC 1,885,956$15,879,7502.72%
Kent Lake Capital LLC 639,775$5,386,9062.43%
Wellington Wealth Strategies, LLC. 71$538,6622.26%
Palo Alto Investors LP 750,371$6,318,1240.73%
BRAIDWELL LP 1,698,768$14,303,6270.45%
ArrowMark Colorado Holdings LLC 4,289,108$36,114,2890.43%
ARMISTICE CAPITAL, LLC 3,672,000$30,918,2400.39%
Rock Springs Capital Management LP 1,381,500$11,632,2300.35%
Eversept Partners, LP 499,395$4,204,9060.29%
Olympiad Research LP 25,046$210,8870.16%
View complete list of NEVRO CORP shareholders